Truist Securities Maintains Hold on Inari Medical, Lowers Price Target to $46

Benzinga · 10/14 14:09
Truist Securities analyst Richard Newitter maintains Inari Medical (NASDAQ:NARI) with a Hold and lowers the price target from $55 to $46.